Priyanka Banerjee

Dr. Priyanka Banerjee


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in The American Journal of Pathology
Verified
Journal Article
Closed access
PBPriyanka Banerjee
Priyanka Banerjee
NGNiyanshi Gaddam
Niyanshi Gaddam
VCVanessa Chandler
Vanessa Chandler
Sanjukta ChakrabortySanjukta Chakraborty
Sanjukta Chakraborty

Verified
Journal Article
Open access
PDF file
PBPriyanka Banerjee
Priyanka Banerjee
NGNiyanshi Gaddam
Niyanshi Gaddam
Tej Krishan PanditaTej Krishan Pandita
Tej Krishan Pandita
Sanjukta ChakrabortySanjukta Chakraborty
Sanjukta Chakraborty
Cellular senescence—the irreversible cell cycle arrest driven by a variety of mechanisms and, more specifically, the senescence-associated secretory phenotype (SASP)—is an important area of research in the context of different age-related diseases, such as cardiovascular disease and cancer. SASP factors play both beneficial and detrimental roles in age-related disease progression depending on the source of the SASPs, the target cells, and the microenvironment. The impact of senescence and the SASP on different cell types, the immune system, and the vascular system has been widely discussed. However, the impact of replicative or stress-induced senescence on lymphatic biology and pathological lymphangiogenesis remains underexplored. The lymphatic system plays a crucial role in the maintenance of body fluid homeostasis and immune surveillance. The perturbation of lymphatic function can hamper normal physiological function. Natural aging or stress-induced premature aging influences the lymphatic vessel structure and function, which significantly affect the role of lymphatics in tumor dissemination and metastasis. In this review, we focus on the role of senescence on lymphatic pathobiology, its impact on cancer, and potential therapeutic interventions to manipulate the aged or senescent lymphatic system for disease management.

6 February 2023 in Cells
Verified
Journal Article
Open access
PDF file
PBPriyanka Banerjee
Priyanka Banerjee
SKSubhashree Kumaravel
Subhashree Kumaravel
SRSukanya Roy
Sukanya Roy
NGNiyanshi Gaddam
Niyanshi Gaddam
JOJohnny Odeh
Johnny Odeh
Sanjukta ChakrabortySanjukta Chakraborty
Sanjukta Chakraborty
Conjugated bile acids (BA) are significantly elevated in several liver pathologies and in the metastatic lymph node (LN). However, the effects of BAs on pathological lymphangiogenesis remains unknown. The current study explores the effects of BAs on lymphangiogenesis. BA levels were elevated in the LN and serum of Mdr2−/− mice (model of sclerosing cholangitis) compared to control mice. Liver and LN tissue sections showed a clear expansion of the lymphatic network in Mdr2−/− mice, indicating activated lymphangiogenic pathways. Human lymphatic endothelial cells (LECs) expressed BA receptors and a direct treatment with conjugated BAs enhanced invasion, migration, and tube formation. BAs also altered the LEC metabolism and upregulated key metabolic genes. Further, BAs induced the production of reactive oxygen species (ROS), that in turn phosphorylated the redox-sensitive kinase p90RSK, an essential regulator of endothelial cell dysfunction and oxidative stress. Activated p90RSK increased the SUMOylation of the Prox1 transcription factor and enhanced VEGFR3 expression and 3-D LEC invasion. BA-induced ROS in the LECs, which led to increased levels of Yes-associated protein (YAP), a lymphangiogenesis regulator. The suppression of cellular YAP inhibited BA-induced VEGFR3 upregulation and lymphangiogenic mechanism. Overall, our data shows the expansion of the lymphatic network in presclerotic liver disease and establishes a novel mechanism whereby BAs promote lymphangiogenesis.